Cigna Group (CI) Projected to Post Quarterly Earnings on Thursday

Cigna Group (NYSE:CI) is projected to announce its Q4 2025 results before the market opens on Thursday, February 5th. Analysts expect the company to announce earnings of $7.90 per share and revenue of $69.5253 billion for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. Cigna Group’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $7.51 EPS. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Stock Up 1.0%

Shares of NYSE CI opened at $272.68 on Thursday. The firm’s 50-day moving average is $274.62 and its 200-day moving average is $284.95. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm has a market capitalization of $72.84 billion, a PE ratio of 12.03, a price-to-earnings-growth ratio of 0.95 and a beta of 0.26.

Insider Buying and Selling

In related news, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Sunbelt Securities Inc. grew its holdings in Cigna Group by 180.5% in the third quarter. Sunbelt Securities Inc. now owns 488 shares of the health services provider’s stock worth $141,000 after purchasing an additional 314 shares during the period. Financial Engines Advisors L.L.C. boosted its holdings in Cigna Group by 235.9% during the 3rd quarter. Financial Engines Advisors L.L.C. now owns 2,963 shares of the health services provider’s stock worth $854,000 after acquiring an additional 2,081 shares during the last quarter. Morningstar Investment Management LLC bought a new stake in Cigna Group in the 3rd quarter worth about $10,287,000. NewEdge Advisors LLC grew its holdings in shares of Cigna Group by 11.3% in the third quarter. NewEdge Advisors LLC now owns 24,745 shares of the health services provider’s stock valued at $7,133,000 after acquiring an additional 2,520 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co increased its position in shares of Cigna Group by 1.8% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 402,543 shares of the health services provider’s stock valued at $115,295,000 after purchasing an additional 7,259 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

CI has been the topic of several recent analyst reports. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 price objective on shares of Cigna Group in a research report on Tuesday, January 6th. JPMorgan Chase & Co. decreased their price target on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research note on Tuesday, November 4th. Wolfe Research lowered their price objective on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. Finally, Wells Fargo & Company decreased their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $330.36.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.